logo

Quick Facts

Share

As per media reports, Qualcomm's (QCOM) proposed $44 billion takeover of NXP Semiconductors (NXPI), is nearing regulatory approval in China. Qualcomm is reportedly planning to meet antitrust regulators in the current week. On April 19, Qualcomm announced that the company and NXP Semiconductors, at...

Swiss Re (SSREY.PK) announced the company and SoftBank Group Corp. (SFTBF.PK) have agreed to end discussions about a potential minority investment of SoftBank in Swiss Re. Swiss Re will explore business ideas between the company's operative entities and the portfolio companies of SoftBank. On February...

ABN AMRO said that its Supervisory Board proposes to appoint Tom de Swaan to the Supervisory Board for a period of four years. Upon approval by the General Meeting, the Supervisory Board will appoint Tom de Swaan as Chairman of the Supervisory Boards of ABN AMRO Group N.V and ABN AMRO Bank N.V. The appointment...

CAE Inc. (CAE.TO, CAE) reported fourth-quarter net income attributable to equity holders from continuing operations of C$100.1 million or C$0.37 per share compared to C$67.4 million or C$0.25 per share, or C$82.4 million or C$0.31 per share before specific items last year. This represents a 19% EPS increase...

Raytheon Co (RTN) announced Friday that the U.S. Army has awarded the company a $395.8 million contract for production of Romania's Patriot Air and Missile Defense System. The contract calls for Raytheon to build Romania's first brand-new Patriot fire unit. Raytheon has already ordered thousands...

SIA and First Data Corp. (FDC) have signed an agreement for SIA to acquire First Data's card processing businesses in parts of Central and Southeastern Europe for 375 million euros. These businesses are primarily located in 7 countries: Greece, Croatia, Czech Republic, Hungary, Romania, Serbia and Slovakia. The...

The Bayer Group (BAYZF.PK, BAYRY.PK, BYR.L) confirmed its currency-adjusted outlook for fiscal 2018. The Group noted that this outlook does not take account of the imminent closing of the Monsanto acquisition. The company continues to anticipate a low- to mid-single-digit percentage increase in sales...

AstraZeneca PLC (AZN.L, AZN) and MedImmune, its global biologics research and development arm, announced positive overall survival results for the Phase III PACIFIC trial, a randomised, double-blinded, placebo-controlled, multi-centre trial of Imfinzi (durvalumab) in patients with unresectable Stage...

Alexion Pharmaceuticals, Inc. (ALXN) announced Friday that its offer for Sweden-based Wilson Therapeutics AB has been declared unconditional. The company noted that shareholders representing 97.7 percent of the total number of shares and votes have accepted the offer. The acquisition has also been approved...

Genmab A/S announced that results from the Phase III study of Arzerra or ofatumumab plus bendamustine did not meet the primary endpoint of improved progression-free survival or PFS in patients with indolent B-cell non-Hodgkin's lymphoma (iNHL) who were unresponsive to rituximab or a rituximab-containing...

Babcock & Wilcox Enterprises, Inc. (BW) confirmed that it had received a non-binding indication of interest from Steel Partners to acquire B&W in a transaction in which B&W shareholders would receive between $3.00 and $3.50 per share in cash. Steel Partners beneficially owns 17.8 percent of B&W's outstanding...

SMA Solar Technology AG (SMTGF.PK) announced its Managing Board confirmed the company's sales and earnings guidance for the 2018 fiscal year, which forecasts sales of between 900 million and 1 billion euros and EBITDA of between 90 million and 110 million euros. At the Annual General Meeting, the...

Clorox Co. (CLX) said its board of directors has authorized the company to repurchase its stock in the open market for an aggregate purchase price of up to $2 billion. Clorox noted that the stock repurchase program is designed to return value to its stockholders and is in addition to the company's...

AbbVie (ABBV) announced that the Phase 3 iLLUMINATE (PCYC-1130) trial met its primary endpoint of improvement in progression-free survival (PFS). The study evaluated IMBRUVICA (ibrutinib) in combination with GAZYVA (obinutuzumab) in previously untreated chronic lymphocytic leukemia or small lymphocytic...

Elliott Management Corporation sent a letter to the Board of Directors of athenahealth, Inc. (ATHN) following up on Elliott's recent proposal to acquire athenahealth for $160 per share in cash. The letter aggregated for the Board the outpouring of positive reactions to Elliott's offer specifically...

Follow RTT